Login / Signup

Percutaneous patent foramen ovale closure for hypoxaemia at the age of 73: a case report showing immediate benefit.

Lars S WitteBart StraverBerto Jorrit BoumaRobbert J de WinterMarcel A M Beijk
Published in: European heart journal. Case reports (2024)
Most PFOs remain clinically insignificant but RLS-mediated hypoxaemia is a rare phenomenon that can occur even at advanced age. Percutaneous PFO closure is a safe and effective therapy option that provides immediate improvement of hypoxaemia.
Keyphrases
  • minimally invasive
  • ultrasound guided
  • radiofrequency ablation
  • stem cells
  • bone marrow
  • replacement therapy